Sun Pharma is to announce its third quarter results. According to CNBC-TV18 estimates, the company's Q3FY09 consolidated net sales are seen up 42% at Rs 1140 crore versus Rs 803 crore, YoY.
Its net profit is expected to go up 43% at Rs 456 crore versus Rs 318 crore.
Its operating profits is seen up at Rs 497 crore verssu Rs 354 crore.
The company's OPM is seen dwon 43.68% versus 44%.